Embecta Corp. (EMBC)
NASDAQ: EMBC · Real-Time Price · USD
10.57
-0.16 (-1.49%)
Feb 23, 2026, 4:00 PM EST - Market closed
Embecta Market Cap
Embecta has a market cap or net worth of $625.95 million as of February 24, 2026. Its market cap has decreased by -40.84% in one year.
Market Cap
625.95M
Enterprise Value
1.83B
1-Year Change
-40.84%
Ranking
Category
Stock Price
$10.57
Market Cap Chart
Since March 22, 2022, Embecta's market cap has decreased from $2.68B to $625.95M, a decrease of -76.61%. That is a compound annual growth rate of -30.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 635.43M | -9.67% |
| Dec 31, 2025 | 703.44M | -41.40% |
| Dec 31, 2024 | 1.20B | 10.14% |
| Dec 29, 2023 | 1.09B | -24.67% |
| Dec 30, 2022 | 1.45B | -45.94% |
| Mar 22, 2022 | 2.68B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AtriCure | 1.62B |
| Kestra Medical Technologies | 1.55B |
| Pulse Biosciences | 1.46B |
| Azenta | 1.35B |
| BioLife Solutions | 1.11B |
| Anbio Biotechnology | 1.08B |
| STAAR Surgical Company | 883.42M |
| Anteris Technologies Global | 551.37M |